UCB (OTCMKTS:UCBJY) Shares Pass Above 50-Day Moving Average of $57.90

UCB SA (OTCMKTS:UCBJY) crossed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $57.90 and traded as high as $64.18. UCB shares last traded at $64.07, with a volume of 71,706 shares.

UCB Stock Up 1.3 %

The business’s fifty day moving average price is $58.48 and its 200 day moving average price is $47.35.

UCB Cuts Dividend

The firm also recently announced a dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Monday, April 29th will be issued a dividend of $0.4574 per share. This represents a yield of 0.71%. The ex-dividend date of this dividend is Friday, April 26th. UCB’s payout ratio is 46.55%.

UCB Company Profile

UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide. The company's primary products include Cimzia for inflammatory TNF mediated diseases, as well as ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis; Vimpat, Keppra, and Briviact for epilepsy; Neupro for Parkinson's disease and restless legs syndrome; Nayzilam, a nasal spray rescue treatment for epilepsy seizure clusters; and Zyrtec and Xyzal for allergies.